Therapeutic benefit of empiric drug sequencing in metastatic renal cell carcinoma.

Viola Chen,Cynthia Gong,Christian R. Hoerner,Chiyuan A. Zhang,Sandy Srinivas,Alice C. Fan

Therapeutic benefit of empiric drug sequencing in metastatic renal cell carcinoma.

2018

Viola Chen
Cynthia Gong
Christian R. Hoerner
Chiyuan A. Zhang
Sandy Srinivas
Alice C. Fan

e16569Background: Multiple targeted therapies (TT) against the VEGFR, mTOR and PD-1 pathways exist to treat metastatic renal cell carcinoma (mRCC). Due to a lack of biomarkers, current practice rel...

Keywords:

Drug
Pathology
Renal cell carcinoma
Medicine
current practice
Oncology
VEGF receptors
PI3K/AKT/mTOR pathway
Internal medicine
Biomarker (medicine)

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations